Avicanna Inc (OP: AVCNF )

0.2995 -0.0048 (-1.58%)

Streaming Delayed Price Updated: 1:41 PM EDT, Oct 2, 2024 Add to My Watchlist

Price and Volume

Volume	68,146
Open	0.3145
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.3043
Today's Range	0.2925 - 0.3145
52wk Range	0.1717 - 0.5320
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?

September 23, 2024

CBD could be deemed toxic for reproduction, which would then lead to its prohibition in cosmetic products across Europe.

Via Benzinga

Avicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical Formula

August 29, 2024

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that it has closed a non-brokered private placement offering of its 6,620,692 ‎‎units at $0.30 per unit for aggregate gross...

Via Benzinga

Performance

YTD	+21.01%	+21.01%
1 Month	-4.86%	-4.86%
3 Month	+19.80%	+19.80%
6 Month	-17.22%	-17.22%
1 Year	-10.44%	-10.44%

More News

Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation

August 27, 2024

Via Benzinga

Avicanna's CBG Products Reach 19 Countries: Denmark Joins Global Expansion

August 15, 2024

Via Benzinga

Avicanna Q2 Revenue Improves 85% YoY, Cannabis Company Touts Two Successful Trials On Drug Candidates

August 15, 2024

Via Benzinga

Latest Cannabis Hires And Board Changes, Here's What You Need To Know

July 12, 2024

Via Benzinga

Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country

July 11, 2024

Via Benzinga

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

June 21, 2024

From Virtual Investor Conferences

Via GlobeNewswire

Life Sciences Virtual Investor Forum Agenda Announced for June 20th

June 18, 2024

From Virtual Investor Conferences

Via GlobeNewswire

CBD-Focused Avicanna Reports First-Ever Adjusted EBITDA Positive Quarter, 451% YoY Spike In Q1 Record Revenue

May 14, 2024

Via Benzinga

CBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa Treatment

May 13, 2024

Via Benzinga

Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY

April 02, 2024

Via Benzinga

This Company Is Bringing Medical Marijuana Telehealth To Over Half The U.S.

March 01, 2024

Via Benzinga

Can Cannabis Treat Severe Forms Of Epilepsy? New Medicine Sparks Hope As Colombia's Weed Industry Goes Global

February 14, 2024

Via Benzinga

CBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply Deal

February 05, 2024

Via Benzinga

CBD-Focused Avicanna Announces Funding Boost For Research And Development

December 05, 2023

Via Benzinga

Avicanna Inc.: Medical Marijuana Sales Reach Record 713% YoY Growth In Q3, Introduces New Platform

November 14, 2023

Via Benzinga

Marijuana Stock Movers For August 23, 2023

August 23, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From August 25, 2023

August 25, 2023

Via Benzinga

Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?

August 15, 2023

Via Benzinga

Bearish Monday For Marijuana Stocks - EVIO, Item 9 Labs Among Top Gainers

August 07, 2023

Via Benzinga

Bullish Thursday For Marijuana Stocks - EVIO, Tetra Bio Pharma Among Top Gainers

August 17, 2023

Via Benzinga

Cannabis Stock Gainers And Losers From August 16, 2023

August 16, 2023

Via Benzinga

Cannabis Stock Movers For August 10, 2023

August 10, 2023

Via Benzinga

Marijuana Stock Movers For August 8, 2023

August 08, 2023

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.